Dong Kim

Insider Reports History

Entity
Individual
Location
C/O Urogen Pharma, Ltd., 400 Alexander Park Drive, 4 Th Floor, Princeton, New Jersey
Signature
/s/ Jason D. Smith, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dong Kim:

Stock Role Class Num Shares Value Price $ Report Date Ownership
UroGen Pharma Ltd. Chief Financial Officer Ordinary Shares 35.3 K $556 K $15.78 Jan 31, 2024 Direct
UroGen Pharma Ltd. Chief Financial Officer Restricted Stock Units 12 K Jan 31, 2024 Direct

Insider Reports Filed by Dong Kim

Symbol Company Period Transactions Value $ Form Type Date Filed Role
URGN UroGen Pharma Ltd. Jan 31, 2024 1 $0 4/A Feb 12, 2024 Chief Financial Officer
URGN UroGen Pharma Ltd. Jan 31, 2024 3 $0 4 Feb 2, 2024 Chief Financial Officer
URGN UroGen Pharma Ltd. Sep 7, 2023 1 $0 4 Sep 8, 2023 Chief Financial Officer
URGN UroGen Pharma Ltd. Jan 31, 2023 2 $0 4 Feb 2, 2023 Chief Financial Officer
URGN UroGen Pharma Ltd. Mar 25, 2022 1 $0 4/A Feb 12, 2024 Chief Financial Officer
URGN UroGen Pharma Ltd. Mar 25, 2022 1 $0 4 Mar 29, 2022 Chief Financial Officer
URGN UroGen Pharma Ltd. Mar 25, 2022 0 $0 3 Mar 29, 2022 Chief Financial Officer